MoneyWorks4Me

The total revenue for the quarter ended March 2023 remained nearly unchanged at Rs. 3643.90 millions.Profit after Tax for the quarter ended March 2023 saw a decline of -42.01% from Rs. 2244.64 millions to Rs. 1301.60  millions.A decline of 1853.81 millions was observed in the OP in the quarter ended March 2023 from 2919.64 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 3643.90 3638.47 0.15 13300.80 13202.22 0.75 13300.80 13202.22 0.75
Other Income 107.55 1343.96 -92.00 445.52 1877.88 -76.28 445.52 1877.88 -76.28
PBIDT 1853.81 2919.64 -36.51 6276.30 7677.76 -18.25 6276.30 7677.76 -18.25
Interest 22.90 21.89 4.61 53.92 62.31 -13.46 53.92 62.31 -13.46
PBDT 1830.91 2897.75 -36.82 6222.38 7615.45 -18.29 6222.38 7615.45 -18.29
Depreciation 106.27 104.21 1.98 428.45 390.97 9.59 428.45 390.97 9.59
PBT 1724.64 2793.54 -38.26 5793.93 7224.48 -19.80 5793.93 7224.48 -19.80
TAX 423.04 548.90 -22.93 1467.91 1643.49 -10.68 1467.91 1643.49 -10.68
Deferred Tax 15.09 34.10 -55.75 43.38 67.19 -35.44 43.38 67.19 -35.44
PAT 1301.60 2244.64 -42.01 4326.02 5580.99 -22.49 4326.02 5580.99 -22.49
Equity 254.57 254.57 0.00 254.57 254.57 0.00 254.57 254.57 0.00
PBIDTM(%) 50.87 80.24 -36.60 47.19 58.16 -18.86 47.19 58.16 -18.86
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..